...
HQLTekla Life Sciences Investors
$16.60
Analysis updated: Jan 16, 2026

Investment Thesis

HQL has middling strength (RS 70/99) and declining earnings. Wait for fundamental turnaround. Smart traders skip this one until the setup improves.

Below-average RS + negative growth = No edge

Key Takeaways

Earnings Momentum

-128%
Q4'22
$-1.10
-1%
Q2'23
$1.29
-132%
Q4'23
$-0.43
+46%
Q2'25
$-1.64
Earnings Declining

Price Structure

Partial Alignment
Price
$16.60
50 DMA
$16.93
100 DMA
$16.13
150 DMA
$15.15
200 DMA
$14.42
Alignment Score: 3/4

HQL Price Chart

Loading chart...

50 DMA150 DMA200 DMA
LEADERSHIP TEST FAILED

Declining/weak EPS with RS < 80. Need either 80+ RS OR super-performer earnings.

Why Not BUY Yet?

RS Rating
70 (Top 30%)>80 (Top 20%)
EPS Growth
N/A>25% Qtr YoY
Pattern
No base formingVCP or constructive base
Entry Point
Broke out 5mo ago, now +21%Wait for pullback or new base

What Would Change Our Mind?

To turn bullish on HQL, we need:

Twin Engines Dashboard

Technical Health

RS Rating
70/99
Top 30% (Need 80+)
Trend
Uptrend
Above 200 DMA
RSI (14)
49
NEUTRAL
VCP Setup
COOL
Score: 3/9
Volume
130K
-5% vs avg
From Entry
+21.4%
$13.67

Fundamental Horsepower

EPS Qtr YoY
N/A
DECLINING
EPS 3Y CAGR
-47%
Annual Earnings
Revenue Qtr
N/A
NO DATA
F-Score
3/9
Piotroski Quality
ROE
6%
Return on Equity
EPS Rank
11/99
Percentile

Trade Plan

Lost Momentum

Broke out 5 months ago at $13.67 — +21% from entry but below EMA support.

Lost momentum. Wait for price to reclaim $16.86 (21 EMA) or form a new base.

Breakout Date2025-08-13156 days ago
Entry Was$13.67Breakout price
Gain Since+21%From entry
Reclaim$16.8621 EMA support

If/Then Playbook

IF: EPS growth turns positive next quarter
THEN: Reassess with fresh eyes
IF: RS Rating improves to >85
THEN: Consider for WATCHLIST if EPS improves

Key Price Levels

Resistance

  • 20 DMA$16.87+1.6%
  • 50 DMA$16.93+2.0%
  • 52W High$17.80+7.2%
Current$16.60

Support

  • 200 DMA$14.42-13.1%
  • 52W Low$10.55-36.4%

Frequently Asked Questions

Is HQL stock a buy now?

HQL has middling strength (RS 70/99) and declining earnings. Wait for fundamental turnaround. Smart traders skip this one until the setup improves.

What is the buy point for HQL?

HQL broke out at $13.67 5 month(s) ago and is now +21% extended. Wait for a pullback to the 21 EMA or a new base pattern.

What is HQL's RS Rating?

HQL has an RS Rating of 70/99, meaning it's in the Top 30% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.

Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.